ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2011

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors.

D J Jonker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.